Moderate Suspected

विवरण

Diltiazem (calcium channel blocker) combined with lithium may increase risk of lithium toxicity and neurotoxic adverse effects including bradycardia.

तंत्र

Diltiazem may reduce lithium renal clearance; calcium channel blockade may also enhance lithium's neurological effects synergistically.

नैदानिक महत्व

Case reports describe neurotoxicity and bradycardia with concurrent lithium and diltiazem; the pharmacokinetic component is less well-characterized than with diuretics.

प्रबंधन

Monitor lithium levels and cardiovascular and neurological status when using diltiazem concurrently; dose adjustments may be needed.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.